Drug Profile
ARH 049020
Latest Information Update: 20 Sep 2001
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Peptides
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Insulin resistance; Type 2 diabetes mellitus
Most Recent Events
- 20 Sep 2001 Discontinued-I for Insulin resistance in United Kingdom (Unknown route)
- 20 Sep 2001 Discontinued-I for Type-2 diabetes mellitus in United Kingdom (Unknown route)
- 28 Jun 2001 New profile